A biologist of the OSE Immunotherapeutics pharmaceutical laboratory works on a program to develop a vaccine against the Covid-19 infection on March 31, 2021 in Nantes, western France. (Photo by LOIC VENANCE / AFP)
A biologist of the OSE Immunotherapeutics pharmaceutical laboratory works on a program to develop a vaccine against the Covid-19 infection on March 31, 2021 in Nantes, western France. (Photo by LOIC VENANCE / AFP)
/ LOIC VENANCE
Por Agencia EFE

Un estudio publicado hoy por médicos de los Hospitales Universitarios de Ginebra (HUG) revela que el coronavirus SARS-CoV-2, causante del COVID-19, puede afectar al sistema nervioso de una forma que reduciría temporalmente el dolor en pacientes con cáncer.